
TELA Bio Announces Publication of 12-Month Results from the BRAVO Study
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the recent publication of the 12-month analysis from the BRAVO Study in the Journal of Clinical Medicine.
TELA Bio Announces Publication of 12-Month Results from the BRAVO Study Read More